[-] Show simple item record

Are ARBs or ACE inhibitors preferred for nephropathy in diabetes?

URI
http://hdl.handle.net/10355/3014
dc.contributor.authorForeman, Brett H.eng
dc.contributor.authorChambliss, M. Leeeng
dc.date.issued2004eng
dc.description.abstractAngiotensin receptor blockers (ARBs) have been shown to reduce the progression of nephropathy in several consistent studies. While ACE inhibitors have not been as well studied for the endpoint of nephropathy, patients with nephropathy exhibit reduced mortality when treated with an ACE inhibitor (strength of recommendation: A, based on randomized controlled trials).eng
dc.identifier.urihttp://hdl.handle.net/10355/3014eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2004 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 53, no. 03 (March 2004): 241-242.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectrenal diseaseeng
dc.subjectmortalityeng
dc.subjectanti-hypertensive therapyeng
dc.subjecttype 2 diabeteseng
dc.subject.lcshDiabetic nephropathieseng
dc.subject.lcshRenal hypertensioneng
dc.subject.lcshDiabetes -- Complicationseng
dc.subject.lcshNon-insulin-dependent diabeteseng
dc.subject.lcshAngiotensin-Converting Enzyme Inhibitorseng
dc.subject.lcshHypertension -- drug therapyeng
dc.titleAre ARBs or ACE inhibitors preferred for nephropathy in diabetes?eng
dc.typeArticleeng


Files in this item

[PDF]
Name:
AreARBOrACEPreferred.pdf
Size:
68.35Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

[-] Show simple item record